Anthem Biosciences Ltd

NSE: ANTHEM · BSE: 544449 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹885.85
Market cap: ₹49,891 Cr
Revenue (annual): ₹2,124 Cr
Net profit (annual): ₹591.8 Cr
P/E (TTM): 86.6×Sector 47.4×
Promoter holding: 71.42%-3.26% QoQ
FII holding: 2.57%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

30 Apr 2026 19:30 IST BSE

Anthem Biosciences Debt & Borrowing: ₹2.96 Cr

Anthem Biosciences Limited confirmed it does not qualify as a 'Large Corporate' under SEBI's debt-raising framework. The company reported outstanding borrowings of ₹2.96 Crore as of March 31, 2026. This disclosure is a routine annual compliance filing for listed entities regarding their bond market borrowing requirements.

Value: ₹2.96 Cr

Read the filing ↗